Mergers & Acquisitions - Respiratory and Pulmonary


Current filters:

Respiratory and Pulmonary

Popular Filters

26 to 32 of 32 results

Sunovion to acquire Elevation Pharma for up to $430 million


Sunovion Pharmaceuticals, a US subsidiary of Japan's Dainippon Sumitomo Pharma (TYO: 4506) last week…

Dainippon Sumitomo PharmaElevation PharmaceuticalsEP-101Mergers & AcquisitionsPharmaceuticalRespiratory and PulmonarySunovion

InterMune to divest Actimmune for $55 million; to focus on Esbriet


California, USA-based biotech firm InterMune (Nasdaq: ITMN) says that it has reached a definitive agreement…

ActimmuneBiotechnologyEsbrietFinancialImmunologicalsInterMuneMergers & AcquisitionsRespiratory and PulmonaryVidara Therapeutics

Valeant pulls out of deal with ISTA, which announces Beposone progress


Acquisitive Canadian drugmaker Valeant Pharmaceuticals International (TSX: VRX) says that it has withdrawn…

BeposoneISTA PharmaceuticalMergers & AcquisitionsOphthalmicsPharmaceuticalResearchRespiratory and PulmonaryValeant Pharmaceuticals

Valeant ups its bid for ISTA Pharma


California, USA-based ophthalmology and allergy drug company ISTA Pharmaceuticals (Nasdaq: ISTA) says…

ISTA PharmaceuticalMergers & AcquisitionsOphthalmicsPharmaceuticalRespiratory and PulmonaryValeant Pharmaceuticals

MedicinesCo takes equity stake in GeNO, gaining access to nitric oxide platforms


USA-based The Medicines Company (Nasdaq: MDCO) says it has acquired a non-controlling equity investment…

GeNOLicensingMergers & AcquisitionsPharmaceuticalRespiratory and PulmonaryThe Medicines Company

26 to 32 of 32 results

Back to top